Universal Health Services, Inc.

Description

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

About

CEO
Mr. Marc D. Miller
Employees
96,700
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Care Facilities
MIC code
XNYS
Address
Universal Corporate Center, King of Prussia, PA 19406-0958, United States
Phone
610 768 3300
Website
Chart Image
× Enlarged Chart
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format

Earnings

Date Estimate EPS Actual EPS Difference % Surprise
Oct 22, 2025
Jul 23, 2025
Apr 22, 2025
Feb 25, 2025 4.21

Earnings estimate

Next Quarter
(Mar 2025)
Next Year
(Dec 2025)
Number of analysts 10 14
Average estimate 4.21 18.16
Low estimate 3.92 16.82
High estimate 4.61 20.08
Last year EPS 3.70 15.92
[stock_revenue_estimate]

Growth estimates

Current qtr
33.400%
Next qtr. (Mar 2025)
13.710%
Current year
51.040%
Next year (Dec 2025)
14.080%
Next 5 years (per annum)
Past 5 years (per annum)

Analyst Ratings

Date Firm Action Rating Price Target
Dec 17, 2024
JP Morgan
Benjamin Rossi
Assumes Neutral Announces $226
Nov 26, 2024
TD Cowen
Ryan Langston
Maintains Buy ▼ Lowers $275 → $251
Nov 25, 2024
Wells Fargo
Stephen Baxter
Maintains Overweight ▼ Lowers $285 → $230
Nov 6, 2024
Wells Fargo
Stephen Baxter
Maintains Overweight ▲ Raises $275 → $285
Oct 28, 2024
RBC Capital
Frank Morgan
Maintains Sector Perform ▼ Lowers $222 → $211
Oct 28, 2024
TD Cowen
Ryan Langston
Maintains Buy ▼ Lowers $283 → $275
Oct 25, 2024
Cantor Fitzgerald
Sarah James
Reiterates Neutral Maintains $219
Oct 25, 2024
Barclays
Andrew Mok
Maintains Overweight ▲ Raises $256 → $271
Oct 22, 2024
Wells Fargo
Stephen Baxter
Maintains Overweight ▲ Raises $255 → $275
Oct 16, 2024
TD Cowen
Ryan Langston
Upgrade Buy ▲ Raises $220 → $283
Oct 11, 2024
Keybanc
Matthew Gillmor
Initiates Sector Weight
Oct 4, 2024
Cantor Fitzgerald
Sarah James
Reiterates Neutral Maintains $219
Oct 1, 2024
Cantor Fitzgerald
Sarah James
Reiterates Neutral Maintains $219
Sep 9, 2024
RBC Capital
Ben Hendrix
Maintains Sector Perform ▲ Raises $189 → $222
Sep 4, 2024
Baird
Michael Ha
Maintains Outperform ▲ Raises $236 → $274
Aug 20, 2024
Cantor Fitzgerald
Sarah James
Reiterates Neutral Maintains $219
Aug 19, 2024
Cantor Fitzgerald
Sarah James
Reiterates Neutral Maintains $219
Aug 14, 2024
UBS
A.J. Rice
Maintains Buy ▲ Raises $247 → $267
Jul 30, 2024
Wells Fargo
Stephen Baxter
Maintains Overweight ▲ Raises $200 → $255
Jul 30, 2024
Goldman Sachs
Jamie Perse
Maintains Buy ▲ Raises $200 → $229
Jul 26, 2024
TD Cowen
Gary Taylor
Maintains Hold ▲ Raises $183 → $220
Jul 26, 2024
Barclays
Andrew Mok
Upgrade Overweight ▲ Raises $198 → $256
Jul 26, 2024
Cantor Fitzgerald
Sarah James
Upgrade Neutral ▲ Raises $162 → $219
Jul 25, 2024
Cantor Fitzgerald
Sarah James
Reiterates Underweight Maintains $162
Jul 25, 2024
Stephens & Co.
Scott Fidel
Reiterates Equal-Weight Maintains $200
Jul 10, 2024
Cantor Fitzgerald
Sarah James
Reiterates Underweight Maintains $162
Jul 10, 2024
Barclays
Andrew Mok
Maintains Equal-Weight ▲ Raises $189 → $198
Jul 9, 2024
Cantor Fitzgerald
Sarah James
Reiterates Underweight Maintains $162
Jul 2, 2024
Cantor Fitzgerald
Sarah James
Reiterates Underweight Maintains $162
Jun 26, 2024
Baird
Michael Ha
Upgrade Outperform ▲ Raises $198 → $236

Income statement

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total reported revenue 14.28B 13.40B 12.64B 11.56B 11.38B
Cost of revenue 1.53B 1.47B 1.43B 1.29B 1.25B
Gross profit 12.75B 11.93B 11.21B 10.27B 10.13B
Operating expense
Research & development
Selling general and admin 7.25B 6.89B 6.28B 5.73B 5.70B
Other operating expenses 3.76B 3.45B 3.04B 2.67B 2.72B
Operating income 1.18B 1.00B 1.36B 1.36B 1.22B
Non operating interest income
Income 572,000 378,000 1.60M 2.80M 469,000
Expense 202.21M 122.36M 83.67M 106.29M 162.73M
Other income expense -28.28M -10.41M 13.89M 14,000 13.16M
Pretax income 940.43M 866.26M 1.29B 1.25B 1.07B
Tax provision 221.12M 209.28M 305.68M 299.29M 238.79M
Net income 719.31M 656.98M 987.63M 952.79M 827.54M
Basic EPS 10.35 9.23 11.99 11.06 9.16
Diluted EPS 10.23 9.14 11.82 10.99 9.13
Basic average shares 69.32M 73.12M 82.52M 85.06M 88.76M
Diluted average shares 69.32M 73.12M 82.52M 85.06M 88.76M
EBITDA 1.71B 1.57B 1.91B 1.87B 1.72B
Net income from continuing op. 719.31M 656.98M 987.63M 952.79M 827.54M
Minority interests -1.51M 18.63M 3.96M -8.84M -12.69M
Preferred stock dividends 308,000 748,000 2.06M 2.98M 2.03M

Balance sheet

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 13.97B 13.49B 13.09B 13.48B 11.67B
Current assets
Cash
Cash equivalents
Cash and cash equivalents 119.44M 102.82M 115.30M 1.22B 61.27M
Other short term investments
Accounts receivable 2.24B 2.02B 1.75B 1.73B 1.56B
Other receivables
Inventory 216.99M 218.52M 206.84M 190.42M 159.89M
Prepaid assets
Restricted cash
Assets held for sale
Hedging assets
Other current assets 236.66M 198.28M 194.78M 138.03M 133.93M
Non current assets
Properties 3.50B 3.39B 3.13B 2.94B 2.76B
Land and improvements 737.23M 727.31M 732.72M 665.00M 613.84M
Machinery furniture equipment 2.94B 2.76B 2.61B 2.43B
Construction in progress 732.18M 562.83M 665.48M 507.40M 376.98M
Leases 101.32M 102.49M 102.94M 75.61M 38.58M
Accumulated depreciation -5.65B -5.17B -4.90B -4.51B -4.09B
Goodwill 7.86B 7.82B 7.93B 7.77B 7.74B
Investment properties
Financial assets
Intangible assets
Investments and advances
Other non current assets 665.35M 674.28M 625.61M 602.66M 539.34M
Total liabilities 7.77B 7.52B 6.90B 7.07B 6.09B
Current liabilities
Accounts payable 613.97M 636.60M 658.90M 570.52M 446.96M
Accrued expenses 490.01M 539.84M 574.44M 535.76M 373.70M
Short term debt 198.29M 149.22M 112.89M 391.79M 143.99M
Deferred revenue 5.38M 2.40M 6,000 376.15M
Tax payable 156.23M 115.50M 171.51M 196.65M 74.12M
Pensions 549.47M 470.86M 466.35M 410.17M 380.12M
Other current liabilities
Non current liabilities
Long term debt 5.17B 5.12B 4.45B 3.80B 4.17B
Provision for risks and charges
Deferred liabilities 5.58M 25.07M
Derivative product liabilities
Other non current liabilities 584.01M 487.67M 464.76M 458.55M 329.93M
Shareholders equity
Common stock 672,000 710,000 771,000 851,000 867,000
Retained earnings 6.80B 6.53B 6.60B 6.75B 5.93B
Other shareholders equity 9.29M -9.67M 30.29M 48.12M 31.89M
Total shareholders equity 6.20B 5.97B 6.20B 6.41B 5.58B
Additional paid in capital
Treasury stock
Minority interest 52.91M 49.46M 108.51M 89.39M 79.10M

Cash flow statement

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891984
Operating Activities
Net Income719.31M656.98M987.63M952.79M827.54M797.88M771.31M747.17M750.70M605.00M554.02M489.05M448.87M275.80M304.25M240.07M170.39M259.46M240.85M169.49M199.27M175.36M99.74M93.36M77.80M79.60M67.30M50.70M35.50M28.70M24.00M20.00M20.30M11.60M9.00M
Depreciation568.04M581.86M533.21M510.49M490.39M453.08M447.88M416.61M398.62M375.62M337.36M308.69M295.86M224.00M204.70M195.77M183.28M163.69M163.71M166.68M144.47M124.79M127.52M112.81M108.30M105.40M80.70M71.90M51.40M42.40M39.60M49.10M35.00M48.50M39.70M
Deferred Taxes3.50M16.20M15.70M-20.80M-9.90M-9.00M-10.00M-10.60M1.70M-3.70M
Stock-Based Compensation87.72M85.38M73.69M65.84M69.43M66.58M56.74M48.11M39.97M31.09M27.78M22.52M18.23M16.80M13.10M14.13M
Other Non-Cash Items-118.09M-141.98M-91.50M-113.09M-97.78M-76.15M-79.19M-81.96M-79.14M-69.65M-70.65M-75.08M-82.63M-50.17M25.00M-124.07M23.39M43.20M16.88M3.39M100,000-100,0006.50M-3.00M17.30M-3.10M1.00M600,000100,000100,000
Accounts Receivable-182.44M-258.34M-8.87M-145.90M-42.06M-42.24M-24.72M-87.88M-45.81M-105.71M-49.71M-71.07M-134.84M22.73M28.12M1.75M-11.54M-93.55M12.98M-29.55M-10.53M-34.99M1.38M-29.39M-38.00M-20.10M-14.40M-100,000-5.10M-4.40M12.90M7.60M-7.70M-23.70M-400,000
Accounts Payable
Other Assets & Liabilities58.31M-133.06M-773.65M927.93M20.16M-8.27M-21.33M130.11M-95.63M90.03M58.70M65.90M7.39M-14.09M-73.86M-51.87M-54.04M-119.11M81.82M44.64M25.03M54.97M15.42M-20.99M15.80M-16.60M-2.80M-5.80M-900,000-3.90M-4.70M-6.80M-11.90M-1.40M1.10M
Operating Cash Flow1.13B790.84M720.51M2.20B1.27B1.19B1.15B1.17B968.71M926.39M857.51M740.00M552.88M475.06M476.31M424.84M288.09M86.42M522.75M394.46M375.12M320.14M247.45M155.79M164.00M151.70M153.50M129.40M77.40M49.80M63.80M60.50M25.20M36.80M45.70M
Investing Activities
Capital Expenditures-743.06M-734.00M-855.66M-731.31M-634.10M-775.43M-580.38M-1.13B-912.98M-822.54M-371.13M-891.04M-315.15M-2.20B-377.94M-272.48M-339.81M-341.14M159.80M-149.47M-198.99M-206.84M-152.94M-113.90M-99.20M-269.70M-165.50M-272.30M-230.40M-70.80M-43.40M-25.40M10.80M-23.90M-18.50M
Net Intangibles19.73M-2.90M-21.42M-36.24M-29.05M-21.48M-13.49M
Net Acquisitions-3.71M-20.21M-105.32M-54.78M-22.58M-15.23M-11.08M-3.30M-12.00M-29.47M-1.96B-12.50M-21.94M-109.74M-81.80M-280.83M-162.93M-281.27M-3.00M-263.46M-141.33M
Purchase of Investments-1.25M-12.27M-1.10M
Sale of Investments
Investing Cash Flow-722.58M-742.21M-935.55M-777.92M-647.23M-777.16M-591.35M-1.17B-912.89M-819.36M-383.46M-789.59M-315.27M-4.15B-390.43M-295.67M-449.55M-278.37M-46.03M-319.72M-454.89M-201.47M-416.40M-251.25M-82.80M-269.70M-165.50M-279.40M-230.30M-71.80M-43.30M-25.40M-2.20M-28.70M-18.50M
Financing Activities
Long-Term Debt Issuance185.10M705.32M3.25B801.60M39.22M791.25M41.10M1.17B247.17M830.00M15.76M913.50M98.10M3.27B26.07M151.13M183.21M494.35M
Long-Term Debt Payments-85.48M-89.37M-3.04B-962.57M-57.14M-830.50M-143.11M-459.18M-68.17M-879.13M-440.22M-849.65M-381.52M-1.39B-66.50M-166.56M-8.72M-34.90M
Other Financing Charges-4.38M-57.06M-12.66M-12.15M-14.41M-28.38M-24.79M-500.03M-62.74M-14.74M-41.44M-19.14M-54.54M-133.67M-29.97M-30.79M16.98M18.83M-1.22M422,00014.54M5.91M-6.61M-100,000100,000100,000-800,000
Financing Cash Flow-493.95M-318.40M-1.07B-384.86M-845.04M-492.20M-519.15M-171.17M-124.61M-187.42M-507.02M-27.40M-413.12M1.71B-147.11M-209.42M102.47M116.11M-254.67M-38.67M-41.27M-67.76M-26.98M-38.36M-87.20M-25.10M1.60M100.30M500,000-12.10M-2.70M-1.80M200,000-5.00M-9.30M
Other Cash Details
End Cash Position214.47M200.84M178.93M1.28B105.67M199.69M167.30M121.95M61.23M32.07M17.24M23.47M41.23M29.47M9.18M5.46M16.35M14.94M7.96M33.13M34.86M17.75M22.85M10.55M6.20M1.30M300,000
Income Tax Paid257.90M250.76M362.98M286.25M260.62M293.84M370.86M344.61M380.66M258.61M259.90M264.82M163.03M152.09M155.37M130.38M93.52M263.47M
Interest Paid200.45M120.14M75.61M112.60M157.41M150.29M135.53M107.08M107.05M130.28M131.26M157.42M176.33M76.90M57.02M62.29M58.57M35.47M
Free Cash Flow524.74M262.02M28.04M1.63B782.96M463.07M638.15M178.63M155.29M199.85M513.11M-91.81M395.54M-1.70B153.56M139.65M8.68M-171.90M184.01M162.12M152.41M124.42M144.61M68.55M76.40M-134.40M-7.20M-128.80M-160.50M-15.10M22.50M41.30M18.50M20.10M17.40M
Error: Invalid format in Holders JSON file.
Universal Health Services: A Quality GARP Company With Significant Upside Article
Universal Health Services: A Quality GARP Company With Significant Upside
Universal Health Services (UHS) remains a BUY due to stable long-term fundamentals, consistent revenue growth, and improving margins. UHS's strong financial performance, including a 45% increase in adjusted diluted EPS and improved EBITDA margins, underscores its resilience and efficiency. With COVID disruptions over, UHS is poised for 6%-7% long-term growth, supported by robust performance in both acute and behavioral health segments.
Seeking Alpha Positive
Feb 9, 2025
Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar Article
Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.
Zacks Investment Research Positive
Feb 3, 2025
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare Video
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare
Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.
CNBC Television Positive
Jan 28, 2025
Scroll to Top

Markets

Crypto

how to invest

Who we are